Trauma-focused CBT Versus EMDR in the Treatment of Posttraumatic Stress Disorder

NCT ID: NCT00716638

Last Updated: 2018-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the effectiveness of trauma-focused cognitive behaviour therapy (TF-CBT) versus eye movement desensitization and reprocessing (EMDR) in the treatment of trauma survivors with post-traumatic stress disorder (PTSD). Patients will be randomly assigned to TF-CBT or EMDR. Follow-up assessments will be conducted at 3 and 12 months post-treatment. In addition to comparing the efficacy of the two protocols, an additional focus will lie on identifying predictors for treatment outcome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Disorders, Post-Traumatic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group 1

Trauma-focused Cognitive Behavior Therapy (TF-CBT)

Group Type EXPERIMENTAL

Trauma-focused Cognitive Behavior Therapy

Intervention Type BEHAVIORAL

This intervention comprises 10 sessions of trauma-focused cognitive behavior therapy for PTSD with the components (a) prolonged imaginal exposure, (b) in vivo exposure, and (c) cognitive restructuring.

Treatment group 2

Eye Movement Desensitization and Reprocessing (EMDR)

Group Type EXPERIMENTAL

Eye Movement Desensitization and Reprocessing (EMDR)

Intervention Type BEHAVIORAL

This intervention comprises 10 sessions of EMDR according to the standard protocol.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trauma-focused Cognitive Behavior Therapy

This intervention comprises 10 sessions of trauma-focused cognitive behavior therapy for PTSD with the components (a) prolonged imaginal exposure, (b) in vivo exposure, and (c) cognitive restructuring.

Intervention Type BEHAVIORAL

Eye Movement Desensitization and Reprocessing (EMDR)

This intervention comprises 10 sessions of EMDR according to the standard protocol.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A full diagnosis of PTSD according to the DSM-IV or subthreshold PTSD (criteria for intrusive re-experiencing are fulfilled and either three avoidance/numbing symptoms or two hyperarousal symptoms are present)
* PTSD is related to one or more single-event traumas and participants have a clear memory of this event/these events (sufficient for constructing scenes to be used in exposure)
* Age between 18 and 70
* Sufficient fluency in Dutch to complete treatment and research protocol
* If participants are using anti-depressants, they need to be on a stable dose for at least 2 weeks before the beginning of treatment and remain on this dose throughout the treatment.

Exclusion Criteria

* Dementia or other severe cognitive impairment
* Psychosis
* Depression with suicidal ideation
* Bipolar disorder
* Borderline Personality Disorder
* Anti-social personality disorder
* Substance dependence
* Current use of tranquilizers
* Exposure to prolonged and/or chronic trauma ("type-II-trauma")
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VU University of Amsterdam

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Paul M.G.Emmelkamp

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Paul MG Emmelkamp, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Amsterdam

Thomas Ehring, PhD

Role: STUDY_DIRECTOR

University of Amsterdam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PsyQ

Zaandam, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008-KP-343

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Treatment for PTSD and Tinnitus
NCT07106593 RECRUITING NA